Zobrazeno 1 - 10
of 69
pro vyhledávání: '"David C. Rice"'
Autor:
Nicolas Zhou, Wayne L. Hofstetter, Stephen G. Swisher, Kyle G. Mitchell, Garrett L. Walsh, Mara B. Antonoff, David C. Rice, Erin M. Corsini, Paul M. Cinciripini, Maher Karam-Hage, Boris Sepesi, Ara A. Vaporciyan, Reza J. Mehran, Jack A. Roth
Publikováno v:
The Annals of Thoracic Surgery. 114:286-292
Background Although smokers are at an increased risk for postoperative pulmonary complications after thoracic surgery, the relationship between cessation timing and postoperative pulmonary complications has not been explored in an era of enhanced rec
Autor:
Mara B. Antonoff, Song Gao, Saumil Gandhi, John V. Heymach, Arlene M. Correa, Vivek Verma, Zhongxing Liao, James W. Welsh, Ravi Rajaram, Wayne L. Hofstetter, Ritsuko Komaki, Garrett L. Walsh, Lei Feng, Joe Y. Chang, Donald A. Berry, Aileen Chen, R Sadagopan, Stephen E. McRae, Peter A Balter, Reza J. Mehran, Matthew S. Ning, Jack A. Roth, Craig DeGraaf, Steven H. Lin, Melenda Jeter, Ara A. Vaporciyan, Xiaochun Wang, Paige L. Nitsch, Michael S. O'Reilly, Quynh-Nhu Nguyen, Boris Sepesi, Julianne M. Pollard-Larkin, David C. Rice, Stephen G. Swisher, Percy Lee
Publikováno v:
Lancet Oncol
Summary Background A previous pooled analysis of the STARS and ROSEL trials showed higher survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early-stage non-small-cell lung cancer (NSCLC), but that analysis had no
Autor:
John V. Heymach, Barbara Mino, J. Jack Lee, Pedro Rocha, Cesar A. Moran, David C. Rice, Edwin R. Parra, Humam Kadara, Boris Sepesi, Lei Feng, Luisa M. Solis, Carmen Behrens, Ignacio I. Wistuba, Don L. Gibbons, Jianjun Zhang, Chad J. Creighton, Jaime Rodriguez-Canales
Publikováno v:
Clinical Lung Cancer. 22:e415-e424
Introduction Immune infiltration in lung adenocarcinomas (LUADs) has been associated with response to immune checkpoint inhibitors. Clinical features underlying differential responses of patients with LUADs to immunotherapy are not well understood. H
Autor:
Cheuk Hong Leung, Wayne L. Hofstetter, John V. Heymach, Alexandre Reuben, Myrna C.B. Godoy, Ara A. Vaporciyan, Padmanee Sharma, Yasir Elamin, Neda Kalhor, Robert R. Jenq, Junya Fujimoto, Tina Cascone, Anne S. Tsao, William N. William, Charles Lu, Frank E. Mott, Nadim J. Ajami, Don L. Gibbons, Jack A. Roth, David C. Rice, Luisa M. Solis, Hai T. Tran, Brett W. Carter, Lauren Averett Byers, Andrew Futreal, Lorenzo Federico, Annikka Weissferdt, Garrett L. Walsh, Reza J. Mehran, Chantale Bernatchez, George R. Blumenschein, Jennifer A. Wargo, Heather Lin, Cara Haymaker, Xiuning Le, Jonathan M. Kurie, Mehmet Altan, James P. Allison, Stephen G. Swisher, Edwin R. Parra, Boris Sepesi, Hitoshi Dejima, Frank V. Fossella, Jianjun Zhang, Bonnie S. Glisson, Mara B. Antonoff, Abdul Wadud Khan, Apar Pataer, Alejandro Francisco-Cruz, Ignacio I. Wistuba, Humam Kadara, J. Jack Lee, Ferdinandos Skoulidis
Publikováno v:
Nat Med
Ipilimumab improves clinical outcomes when combined with nivolumab in metastatic non-small cell lung cancer (NSCLC), but its efficacy and impact on the immune microenvironment in operable NSCLC remain unclear. We report the results of the phase 2 ran
Autor:
John V. Heymach, David C. Rice, Neda Kalhor, William N. William, Frank V. Fossella, Don L. Gibbons, Annikka Weissferdt, Vincent K. Lam, Stephen G. Swisher, Ara A. Vaporciyan, Frank E. Mott, Heather Lin, Boris Sepesi, J. Jack Lee, Ignacio I. Wistuba, Edwin R. Parra, Reza J. Mehran, Carmen Behrens, Anne S. Tsao, Mei Jiang, Jianjun Zhang, Tina Cascone, Cesar A. Moran, Charles Lu, Myrna C.B. Godoy, George R. Simon, Mara B. Antonoff
Publikováno v:
Clinical Cancer Research. 26:3525-3536
Purpose: Nintedanib enhances the activity of chemotherapy in metastatic non–small cell lung cancer (NSCLC). In this phase I/II study, we assessed safety and efficacy of nintedanib plus neoadjuvant chemotherapy, using major pathologic response (MPR)
Autor:
Tina Cascone, Ting Xu, Quynh Nhu Nguyen, David C. Rice, Jack A. Roth, Saumil Gandhi, Wayne L. Hofstetter, Zhongxing Liao, Arlene M. Correa, Mara B. Antonoff, Anne S. Tsao, Ara A. Vaporciyan, Reza J. Mehran, Ravi Rajaram, Stephen G. Swisher, Boris Sepesi, Vassiliki A. Papadimitrakopoulou, Garrett L. Walsh
Publikováno v:
Clinical Lung Cancer. 21:e294-e301
Introduction The standard of care for stage IIIA (N2) non–small-cell lung cancer (NSCLC) includes concurrent definitive chemoradiation (dCRT) followed by durvalumab, thus challenging the role of surgery in resectable patients. We assessed locoregio
Autor:
Eric L. Brown, Garrett L. Walsh, Reza J. Mehran, Luis G LeonNovelo, Jack A. Roth, Jitesh B. Shewale, Arlene M. Correa, Ara A. Vaporciyan, Wayne L. Hofstetter, Boris Sepesi, Erin M. Corsini, Mara B. Antonoff, Stephen G. Swisher, David C. Rice, Alan G. Nyitray
Publikováno v:
Journal of Surgical Oncology. 122:495-505
Background The improvement in the management of lung cancer have the potential to improve survival in patients undergoing resection for early-stage (stage I and II) non-small cell lung cancer (NSCLC), but few studies have evaluated time trends and id
Autor:
Robert J. Cerfolio, Michael S. Kent, David C. Rice, Thomas Fabian, Matthew G. Hartwig, Kimble G Jett, Richard S. Lazzaro, Rishindra M. Reddy, Michael Zervos, Inderpal S. Sarkaria, William B Tisol, Abbas E. Abbas, Bryan F. Meyers, Michael F. Reed, Patrick Ross, Mark R. Dylewski, Dennis A. Wigle, Brian Mitzman, Eric Vallières, Lana Y Schumacher, Luis J. Herrera
Publikováno v:
Annals of surgery.
OBJECTIVE The aim of this study was to analyze outcomes of open lobectomy (OL), video-assisted thoracoscopic lobectomy (VATS) and robotic-assisted lobectomy (RL). SUMMARY BACKGROUND DATA Robotic-assisted lobectomy has seen increasing adoption for tre
Autor:
Alex A. Adjei, David H. Harpole, Ritu R. Gill, Charles B. Simone, Ellen Yorke, Andreas Rimner, Anne S. Tsao, B.C. John Cho, Andrew A. Jackson, Valerie W. Rusch, Harvey I. Pass, Marc de Perrot, Daniel R. Gomez, Fred R. Hirsch, Raphael Bueno, Mary Hesdorffer, David C. Rice, Kenneth E. Rosenzweig
Publikováno v:
Journal of Thoracic Oncology. 14:1172-1183
Introduction Detailed guidelines regarding the use of radiation therapy for malignant pleural mesothelioma (MPM) are currently lacking because of the rarity of the disease, the wide spectrum of clinical presentations, and the paucity of high-level da
Autor:
Garrett L. Walsh, Ahsan Farooqi, Kyle G. Mitchell, A. Vaporciyan, David C. Rice, Wayne L. Hofstetter, R. Mehran, Daniel R. Gomez, S. Gandhi, Ethan B. Ludmir, Ravi Rajaram, S.G. Swisher, Boris Sepesi, Mara B. Antonoff, Hope A. Feldman
Publikováno v:
Journal of Thoracic Oncology. 16:S885-S886